Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
52.80
-1.30 (-2.40%)
Apr 17, 2026, 1:30 PM CST
TPEX:4747 Market Cap
TPEX:4747 has a market cap or net worth of 2.4 billion as of April 17, 2026. Its market cap has decreased by -37.11% in one year.
Market Cap
2.40B
Enterprise Value
1.51B
Revenue
569.77M
Ranking
n/a
PE Ratio
44.52
Stock Price
52.80
Market Cap Chart
Since January 8, 2010, TPEX:4747's market cap has increased from 500.25M to 2.40B, an increase of 378.98%. That is a compound annual growth rate of 10.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.40B | -9.92% |
| Dec 31, 2025 | 2.66B | -17.20% |
| Dec 31, 2024 | 3.21B | -12.10% |
| Dec 29, 2023 | 3.66B | 137.81% |
| Dec 30, 2022 | 1.54B | 46.08% |
| Dec 29, 2021 | 1.05B | -5.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient EuroPharma | 4.11B |
| Merdury Biopharmaceutical | 3.43B |
| Maywufa Company | 2.90B |
| Allied Biotech | 2.77B |
| PhytoHealth | 2.51B |
| TSH Biopharm Corporation | 1.95B |
| Tien Liang BioTech | 1.72B |
| GeneFerm Biotechnology | 1.64B |